WHITNEY SEEBER: Open Payments
NPI 1346834967 · DOUBLE OAK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$185 in 5 payments from 4 companies in 2025. Trend: 2023 $121 · 2024 $143 · 2025 $185
Food & beverage: $185
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $90 |
| AstraZeneca Pharmaceuticals LP | 2 | $42 |
| Corcept Therapeutics | 1 | $39 |
| Esperion Therapeutics, Inc. | 1 | $14 |
Products named: Wegovy, FARXIGA, Korlym, NEXLETOL.
Industry payments across TX — which companies pay providers there.
